NCT00828906

Brief Summary

To evaluate the effectiveness of DuoTrav Eye Drops in gaining or maintaining control of target Intraocular Pressures (tIOP) in patients diagnosed with, and being treated for, open-angle glaucoma (OAG) or ocular hypertension (OH).

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 26, 2009

Completed
6 days until next milestone

Study Start

First participant enrolled

February 1, 2009

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2009

Completed
Last Updated

September 20, 2012

Status Verified

July 1, 2012

Enrollment Period

9 months

First QC Date

January 23, 2009

Last Update Submit

September 18, 2012

Conditions

Open-angle GlaucomaOcular Hypertension

Keywords

GlaucomaIOPDuoTrav

Outcome Measures

Primary Outcomes (1)

  • Intra Ocular Pressure

    visit 1, Visits 2-3, Visits 6-8

Study Arms (1)

1

EXPERIMENTAL

DuoTrav

Drug: DuoTrav

Interventions

DuoTravDRUG

DuoTrav Eye Drops

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with OAG or OH for whom single agent therapy provides insufficient intraocular pressure reduction

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Contact Alcon for Trial Locations

Beijing, China

Location

MeSH Terms

Conditions

Glaucoma, Open-AngleOcular HypertensionGlaucoma

Interventions

Duotrav

Condition Hierarchy (Ancestors)

Eye Diseases

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 23, 2009

First Posted

January 26, 2009

Study Start

February 1, 2009

Primary Completion

November 1, 2009

Last Updated

September 20, 2012

Record last verified: 2012-07

Locations

CN(1)